E-DRUG: National guidelines for anticoagulation treatment - copyright problems
------------------------------------------------------------------------
[A story of how unexpected events can impact publication of clinical guidelines based on those from other parties. It would be interesting to know more about the backstory and whether this could become an issue for developing countries that base their guidelines on those derived by private/professional groups. DB]
Colleagues
Norwegian national guidelines for anticoagulation treatment were ready for publication early this year. But publication is delayed due to copyright reasons.
The American guidelines are published by the American College of Chest Physicians, ACCP, in their journal Chest. The Norwegian guidelines are similar to the American guidelines except for atrial fibrillation which is based on the guidelines from the European Society of Cardiology.
The disagreement is linked to the guidelines being published by the Norwegian health authorities. ACCP is setting terms for publishing licence which the Norwegian health authorities cannot accept.
One way around the problem may be to publish the guidelines via a newly established professional society. But in any case there will be a delay of several months.
I am surprised and worried by this kind of dispute.
Stein Lyftingsmo
Pharmacist
Elverum, Norway
stein@lyftingsmo.no
www.lyftingsmo.no